| Recombinant human endostatin | |
|---|---|
| Generic/working name | Recombinant human endostatin |
| Trade name | Endostar |
| Company name | Nanjing Simcere-Medgenn Bio-Pharmaceuticals Company |
| Drug type | Biological |
| Drug class | Angiogenesis-antivascular |
| Dose | 15mg/m² |
| Route | Continuous intravenous infusion |
| Schedule of administration | Rh-endostatin (15mg/m2) was administered daily as a continuous intravenous pump infusion (7 continuous days) every 3 weeks. |
| Irinotecan | |
| Generic/working name | Irinotecan |
| Trade name | Campto |
| Company name | Pfizer Inc. |
| Drug type | Biological |
| Drug class | Topoisomerase I |
| Dose | 60mg/m² |
| Route | i.v. |
| Schedule of administration | Irinotecan (60mg/m2) was administered intravenously on day 1 and day 8 every 3 weeks. |
| Cisplatin | |
| Generic/working name | Cisplatin |
| Trade name | Nuoxin |
| Company name | HANSOH PHARMA. Inc |
| Drug type | Small molecule |
| Drug class | Platinum compound |
| Dose | 60mg/m² |
| Route | i.v. |
| Schedule of administration | Cisplatin (60mg/m2) was administered intravenously on day 1 every 3 weeks. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.